pharmaphorum
MAY 6, 2022
Throughout my 30-year career, there have been many times it was obvious I stood out just because of my gender. I was often the only woman in the room, the meeting, or on the committee. Many colleagues had never worked with a woman leader before, let alone reported to a female boss. I’ve certainly faced barriers – sometimes literally. Exclusive behavior has many faces.
Pharma Times
MAY 6, 2022
WHO have stated that Veklury recommendation is being updated following compelling new evidence of hospital reductions
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MAY 6, 2022
Sanofi has completed the spin-out of its pharma ingredients business EuroAPI, with shares in the new company rising more than 3% on its starting price of €12 in early trading on the Euronext exchange this morning in a declining market. The separation makes EuroAPI the world’s single largest producer of small-molecule active pharmaceutical ingredients (APIs) – and the second-largest API producer overall after Israel’s Teva – with a market valuation of more than $1.2 billion.
Pharma Times
MAY 6, 2022
Norfolk and Norwich University Hospitals Foundation Trust opens centre to increase survival rate among pregnant women managing other conditions
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
MAY 6, 2022
A digital therapeutic (DTx) developed to help people suffering from insomnia has been shown to improve sleep and mental health in people recovering from a stroke in a clinical trial. The use of the Sleepio app improved sleep quality in 48% of patients enrolled into the study, which was conducted with the University of Oxford. The study found Sleepio users experienced less depression and anxiety after eight weeks follow-up, according to the results, which were presented this week at the European
pharmaphorum
MAY 6, 2022
Biogen has licensed rights to a digital therapeutic (DTx) developed by MedRhythms which combines sensors, software, and music to help people with multiple sclerosis tackle mobility problems. The biopharma company – which is one of the top players in MS drug therapies – is paying $3 million upfront to claim rights to the DTx, known as MR-004, and is also on the hook for an additional $117.5 million in development and commercial milestones plus royalties on any eventual sales.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
pharmaphorum
MAY 6, 2022
For life science companies around the world, enabling faster access to innovative drugs and therapies is a complicated challenge. As this issue’s contributors discuss, changes in technologies and processes across the industry are disrupting traditional market access solutions and creating opportunities for companies to explore new avenues for innovation.
pharmaphorum
MAY 6, 2022
Novartis has shut down production of its radioligand therapies – one of its key growth areas – at facilities in Europe and the US after discovering potential quality issues at the plants. The suspension affects sites at Ivrea in Italy and Millburn in New Jersey, and will affect both commercial and clinical trial supplies of its Lutathera for neuroendocrine tumours (NET) and recently-approved prostate cancer therapy Pluvicto.
pharmaphorum
MAY 6, 2022
Forget the number of deaths worldwide from COVID-19 estimated by the various trackers of around six million. The true figures is much higher, at nearly 15 million, according to the World Health Organisation (WHO). The agency believes many countries have underestimated the number of deaths that can be directly or indirectly attributed to the coronavirus, in some cases by a massive margin.
Expert insights. Personalized for you.
94 
Let's personalize your content